MedPath

Therapeutic effects of Dosin (Nigella sativa and Honey) vaginal Cream on Candida Vulvovaginitis

Phase 2
Recruiting
Conditions
Candida VulvoVaginitis.
Candidiasis of vulva and vagina (N77.1*)
B37.3
Registration Number
IRCT20190711044176N1
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
84
Inclusion Criteria

Women were married and aged between 18-49 years old
Not being pregnancy
Not being lactation
Not Having Allergy to Honey or Nigella Sativa or Clotrimazole
Not being period
Not using vaginal cream and vaginal doush and for last 48 hours before the study
Not Having of history of diabetes and deficiency of immune system
Not Having recurrent Candida vaginitis (4 or more Candida vaginitis in a year)
Not Having of history of curettage, Hysterosalpingography and uterine surgery in the last two weeks
No history of receiving blood or chemotherapy in a recent month
Having of signs and symptoms of Candida vaginitis, positive direct smear and culther of vaginal discharge

Exclusion Criteria

Not Agreeing to Participate in the Study
The use of antibiotics to treat non-vaginitis systemic infections during treatment
Participation at another trial
Pregnancy in the study time table

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Symptoms and signs of Candida Vulvovaginitis. Timepoint: Before intervention, 6-10 day after treatment. Method of measurement: Questionnaire,Microscopic evaluation,Secretion culture,Measurements Of Ph.
Secondary Outcome Measures
NameTimeMethod
Improve Of Candida Vulvovaginitis. Timepoint: 6-10 Day After Treatment. Method of measurement: Questionnaire, culther.
© Copyright 2025. All Rights Reserved by MedPath